<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02345954</url>
  </required_header>
  <id_info>
    <org_study_id>lapSKPvslapHP</org_study_id>
    <nct_id>NCT02345954</nct_id>
  </id_info>
  <brief_title>Laparoscopic Supracervical Hysterectomy and Sacropexy Versus Hysteropexy Study</brief_title>
  <acronym>HysPex</acronym>
  <official_title>Laparoscopic Supracervical Hysterectomy and Sacropexy Compared to Uterus Conserving Hysteropexy: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Aarau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kantonsspital Aarau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the operative, anatomic functional outcome as well as
      the subjective outcome of laparoscopic supracervical hysterectomy and sacropexy compared to
      laparoscopic hysteropexy (conserving the uterus).

      The investigators expect that both laparoscopic procedures are equal in regards to operation
      time, complication rate, anatomic and functional outcome as well as subjective outcome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Operation time</measure>
    <time_frame>expected average of 150 minutes</time_frame>
    <description>Comparison of operation time in the 2 arms of the study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intra- and postoperative complication rate</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of anaesthesia</measure>
    <time_frame>expected average of 200 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IUGA Pelvic Organ Prolapse Quantification (POP-Q)</measure>
    <time_frame>8 weeks before surgical intervention and at follow up 6 weeks, 6 months and 12 months after intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bladder and bowel function, Prolapse symptoms, Sexuality</measure>
    <time_frame>8 weeks before surgical intervention and at follow up 6 weeks, 6 months and 12 months after intervention</time_frame>
    <description>Assessed via Pelvic Function Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>8 weeks before surgical intervention and at follow up 6 weeks, 6 months and 12 months after intervention</time_frame>
    <description>EQ-5D-5L questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction after surgery</measure>
    <time_frame>At follow up 6 weeks, 6 months and 12 months after intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Uterus Prolapse</condition>
  <arm_group>
    <arm_group_label>Supracervical Hysterectomy and Sacropexy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopic Supracervical Hysterectomy and Sacropexy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hysteropexy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopic Hysteropexy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic Supracervical Hysterectomy and Sacropexy</intervention_name>
    <description>Laparoscopic supracervical hysterectomy and laparoscopic sacrocolpopexy</description>
    <arm_group_label>Supracervical Hysterectomy and Sacropexy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic Hysteropexy</intervention_name>
    <description>Laparoscopic hysteropexy</description>
    <arm_group_label>Hysteropexy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 years

          -  Symptomatic uterus prolapse (uterus &lt; 300g)

          -  Patient able to sign the informed consent and to fulfil the follow up visits

        Exclusion Criteria:

          -  Indication: Pathologies of the uterus (postmen. bleeding, high endometrium at
             ultrasound (&gt;5 mm), abnormal PAP smear in the last 5 years, bleeding anomalies in
             premenopausal patients

          -  General medical contraindications to a surgical operation

               -  tumor/ malignant disease

               -  bacterial infection at time of surgery

               -  drug or medication abuse at time or just before surfer

          -  Disease which would make a correct assessment of the patient impossible (e.g.
             psychiatric condition)

          -  Known hypersensitivity to the implanted materials

          -  Immaturity, inability to answer/understand questions

          -  Planned pregnancy

          -  Participation to other studies (drugs or medical techniques) which could influence the
             results of this study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dimitri Sarlos, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Kantonsspital Aarau</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dimitri Sarlos, MD</last_name>
    <phone>+41 838 5065</phone>
    <email>dimitri.sarlos@ksa.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Jacques Ries, MD</last_name>
    <phone>+41 838 5995</phone>
    <email>Jean-Jacques.Ries@ksa.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kantonsspital Aarau</name>
      <address>
        <city>Aarau</city>
        <state>Aargau (AG)</state>
        <zip>5001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dimitri Sarlos, MD</last_name>
      <phone>+41 62 838 5065</phone>
      <email>dimitri.sarlos@ksa.ch</email>
    </contact>
    <contact_backup>
      <last_name>Jean-Jacques Ries, MD</last_name>
      <phone>+41 62 838 5995</phone>
      <email>Jean-Jacques.Ries@ksa.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Dimitri Sarlos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gabriel Schär, Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Sarlos D, Kots L, Stevanovic N, von Felten S, Schär G. Robotic compared with conventional laparoscopic hysterectomy: a randomized controlled trial. Obstet Gynecol. 2012 Sep;120(3):604-11. doi: 10.1097/AOG.0b013e318265b61a.</citation>
    <PMID>22914470</PMID>
  </reference>
  <reference>
    <citation>Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol. 2009 Dec;114(6):1278-83. doi: 10.1097/AOG.0b013e3181c2ce96.</citation>
    <PMID>19935030</PMID>
  </reference>
  <reference>
    <citation>Khunda A, Vashisht A, Cutner A. New procedures for uterine prolapse. Best Pract Res Clin Obstet Gynaecol. 2013 Jun;27(3):363-79. doi: 10.1016/j.bpobgyn.2012.12.004. Epub 2013 Jan 5. Review.</citation>
    <PMID>23298608</PMID>
  </reference>
  <reference>
    <citation>Krause HG, Goh JT, Sloane K, Higgs P, Carey MP. Laparoscopic sacral suture hysteropexy for uterine prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jun;17(4):378-81. Epub 2005 Nov 30.</citation>
    <PMID>16319998</PMID>
  </reference>
  <reference>
    <citation>Price N, Slack A, Jackson SR. Laparoscopic hysteropexy: the initial results of a uterine suspension procedure for uterovaginal prolapse. BJOG. 2010 Jan;117(1):62-8. doi: 10.1111/j.1471-0528.2009.02396.x.</citation>
    <PMID>20002370</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2014</study_first_submitted>
  <study_first_submitted_qc>January 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2015</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kantonsspital Aarau</investigator_affiliation>
    <investigator_full_name>Dimitri Sarlos</investigator_full_name>
    <investigator_title>Chair Department of Gynecology</investigator_title>
  </responsible_party>
  <keyword>Uterus Prolapse</keyword>
  <keyword>Laparoscopic Sacropexy</keyword>
  <keyword>Laparoscopic Hysteropexy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Uterine Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

